1. Home
  2. SGHT vs III Comparison

SGHT vs III Comparison

Compare SGHT & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$5.02

Market Cap

235.0M

Sector

Health Care

ML Signal

HOLD

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.09

Market Cap

203.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
III
Founded
2011
2006
Country
United States
United States
Employees
N/A
1500
Industry
Medical Specialities
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
235.0M
203.8M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
SGHT
III
Price
$5.02
$4.09
Analyst Decision
Buy
Buy
Analyst Count
7
1
Target Price
$9.08
$5.50
AVG Volume (30 Days)
126.9K
206.3K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
4.46%
EPS Growth
28.16
216.67
EPS
N/A
0.05
Revenue
$77,363,000.00
$192,745,000.00
Revenue This Year
$11.67
$3.85
Revenue Next Year
$10.39
$4.34
P/E Ratio
N/A
$84.20
Revenue Growth
N/A
4.51
52 Week Low
$3.11
$3.74
52 Week High
$9.24
$6.45

Technical Indicators

Market Signals
Indicator
SGHT
III
Relative Strength Index (RSI) 56.42 41.20
Support Level $4.76 $3.95
Resistance Level $5.25 $4.37
Average True Range (ATR) 0.29 0.13
MACD 0.02 -0.04
Stochastic Oscillator 73.73 11.22

Price Performance

Historical Comparison
SGHT
III

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

Share on Social Networks: